These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20581678)

  • 1. Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance.
    Savage DB; Semple RK
    Curr Opin Lipidol; 2010 Aug; 21(4):329-36. PubMed ID: 20581678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease.
    Zhang XQ; Xu CF; Yu CH; Chen WX; Li YM
    World J Gastroenterol; 2014 Feb; 20(7):1768-76. PubMed ID: 24587654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease.
    Gaggini M; Morelli M; Buzzigoli E; DeFronzo RA; Bugianesi E; Gastaldelli A
    Nutrients; 2013 May; 5(5):1544-60. PubMed ID: 23666091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease.
    Gentile CL; Frye M; Pagliassotti MJ
    Antioxid Redox Signal; 2011 Jul; 15(2):505-21. PubMed ID: 21128705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress in nonalcoholic fatty liver disease.
    Pagliassotti MJ
    Annu Rev Nutr; 2012 Aug; 32():17-33. PubMed ID: 22809102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis.
    Glimcher LH; Lee AH
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1(Suppl 1):E2-9. PubMed ID: 19751410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subset of dysregulated metabolic and survival genes is associated with severity of hepatic steatosis in obese Zucker rats.
    Buqué X; Martínez MJ; Cano A; Miquilena-Colina ME; García-Monzón C; Aspichueta P; Ochoa B
    J Lipid Res; 2010 Mar; 51(3):500-13. PubMed ID: 19783528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER Unfolded Protein Response in Liver In Vivo Is Characterized by Reduced, Not Increased, De Novo Lipogenesis and Cholesterol Synthesis Rates with Uptake of Fatty Acids from Adipose Tissue: Integrated Gene Expression, Translation Rates and Metabolic Fluxes.
    Ward CP; Peng L; Yuen S; Chang M; Karapetyan R; Nyangau E; Mohammed H; Palacios H; Ziari N; Joe LK; Frakes AE; Dandan M; Dillin A; Hellerstein MK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
    Geisler CE; Renquist BJ
    J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
    Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
    Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME; Garcimartin A; Muñoz-Martínez E
    Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
    Jornayvaz FR; Samuel VT; Shulman GI
    Annu Rev Nutr; 2010 Aug; 30():273-90. PubMed ID: 20645852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.
    Lake AD; Novak P; Hardwick RN; Flores-Keown B; Zhao F; Klimecki WT; Cherrington NJ
    Toxicol Sci; 2014 Jan; 137(1):26-35. PubMed ID: 24097666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty liver, insulin resistance, and dyslipidemia.
    Adiels M; Taskinen MR; Borén J
    Curr Diab Rep; 2008 Feb; 8(1):60-4. PubMed ID: 18367000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum proteostasis in hepatic steatosis.
    Baiceanu A; Mesdom P; Lagouge M; Foufelle F
    Nat Rev Endocrinol; 2016 Dec; 12(12):710-722. PubMed ID: 27516341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure.
    Kwok A; Zvetkova I; Virtue S; Luijten I; Huang-Doran I; Tomlinson P; Bulger DA; West J; Murfitt S; Griffin J; Alam R; Hart D; Knox R; Voshol P; Vidal-Puig A; Jensen J; O'Rahilly S; Semple RK
    Mol Metab; 2020 Oct; 40():101020. PubMed ID: 32439336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pex11a deficiency causes dyslipidaemia and obesity in mice.
    Chen C; Wang H; Chen B; Chen D; Lu C; Li H; Qian Y; Tan Y; Weng H; Cai L
    J Cell Mol Med; 2019 Mar; 23(3):2020-2031. PubMed ID: 30585412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic fatty liver disease in dyslipidemia and insulin resistance: similarities and differences; differential approach to therapy].
    Lazebnik LB; Zvenigorodskaia LA; Egorova EG; Mel'nikova NV; Khomeriki SG
    Eksp Klin Gastroenterol; 2009; (8):4-11. PubMed ID: 20469672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.